The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies.
复制标题

DOI:
10.3390/v13061158
复制
发表时间:
2021-06-17
期刊:
Viruses
影响因子:
--
通讯作者:
Chiocca EA
Chiocca EA
中科院分区:
其他
文献类型:
--
作者:
Bernstock JD;Hoffman SE;Chen JA;Gupta S;Kappel AD;Smith TR;Chiocca EA

文献摘要

参考文献

被引文献

相似文献

尽管手术切除和放化疗取得了进展,但高级别脑肿瘤仍然与显着的发病率/死亡率相关。因此,患者及其家人迫切需要新的治疗策略和方法。鉴于在治疗多种其他形式的癌症方面取得的成功经验,免疫疗法,特别是免疫病毒疗法处于目前正在研究的针对无法治愈的脑肿瘤的新型治疗策略中的最前沿。因此,在此,我们对临床试验中正在研究的相关溶瘤疱疹病毒(oHSV)进行了重点简要回顾。
Despite advances in surgical resection and chemoradiation, high-grade brain tumors continue to be associated with significant morbidity/mortality. Novel therapeutic strategies and approaches are, therefore, desperately needed for patients and their families. Given the success experienced in treating multiple other forms of cancer, immunotherapy and, in particular, immunovirotherapy are at the forefront amongst novel therapeutic strategies that are currently under investigation for incurable brain tumors. Accordingly, herein, we provide a focused mini review of pertinent oncolytic herpes viruses (oHSV) that are being investigated in clinical trials.
DOI: 10.1158/0008-5472.can-06-3145
发表时间: 2007-01-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Aghi, Manish;Rabkin, Samuel D.;Martuza, Robert L.
通讯作者: Martuza, Robert L.
DOI: 10.1038/mt.2014.22
发表时间: 2014-05-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Markert, James M.;Razdan, Shantanu N.;Gillespie, G. Yancey
通讯作者: Gillespie, G. Yancey
DOI: 10.1158/0008-5472.can-04-3793
发表时间: 2005-06-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Hadjipanayis, CG;DeLuca, NA
通讯作者: DeLuca, NA
DOI: 10.1084/jem.187.3.341
发表时间: 1998-02-02
影响因子: 15.3
作者:
Goldsmith, K;Chen, W;Johnson, DC;Hendricks, RL
通讯作者: Hendricks, RL
DOI: 10.1038/s41598-018-32353-x
发表时间: 2018-09-17
期刊: Scientific reports
影响因子: 4.6
作者:
Friedman GK;Bernstock JD;Chen D;Nan L;Moore BP;Kelly VM;Youngblood SL;Langford CP;Han X;Ring EK;Beierle EA;Gillespie GY;Markert JM
通讯作者: Markert JM